
1. Bogan KL, Brenner C. Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD⁺ precursor vitamins. *Annu Rev Nutr*. 2008;28:115–130. doi:10.1146/annurev.nutr.28.061807.155443
2. Verdin E. NAD⁺ in aging, metabolism, and neurodegeneration. *Science*. 2015;350(6265):1208–1213. doi:10.1126/science.aac4854
3. Imai SI, Guarente L. NAD⁺ and sirtuins in aging and disease. *Trends Cell Biol*. 2014;24(8):464–471. doi:10.1016/j.tcb.2014.04.002
4. Ying W. NAD⁺ and NADH in cellular functions and cell death. *Front Biosci*. 2006;11:3129–3148. doi:10.2741/2038
5. Rajman L, et al. Therapeutic potential of NAD⁺ precursors in health and disease. *Nat Rev Drug Discov*. 2018;17(9):651–669. doi:10.1038/nrd.2018.98
6. Lautrup S, et al. NAD⁺ in brain aging and neurodegenerative disorders. *Cell Metab*. 2019;30(4):630–655. doi:10.1016/j.cmet.2019.09.001
7. Canto C, et al. NAD⁺ metabolism and the control of energy homeostasis. *Trends Mol Med*. 2015;21(6):429–441. doi:10.1016/j.molmed.2015.03.001
8. Yoshino J, et al. Nicotinamide mononucleotide, a key NAD⁺ intermediate, treats diet- and age-induced diabetes in mice. *Cell Metab*. 2011;14(4):528–536. doi:10.1016/j.cmet.2011.08.014
9. Trammell SAJ, et al. Nicotinamide riboside is a newly discovered NAD⁺ precursor vitamin in humans. *Nat Commun*. 2016;7:12948. doi:10.1038/ncomms12948
10. Fang EF, et al. NAD⁺ replenishment improves mitochondrial and stem cell function and enhances life span in mice. *Science*. 2016;352(6292):1436–1443. doi:10.1126/science.aaf2693
2. Verdin E. NAD⁺ in aging, metabolism, and neurodegeneration. *Science*. 2015;350(6265):1208–1213. doi:10.1126/science.aac4854
3. Imai SI, Guarente L. NAD⁺ and sirtuins in aging and disease. *Trends Cell Biol*. 2014;24(8):464–471. doi:10.1016/j.tcb.2014.04.002
4. Ying W. NAD⁺ and NADH in cellular functions and cell death. *Front Biosci*. 2006;11:3129–3148. doi:10.2741/2038
5. Rajman L, et al. Therapeutic potential of NAD⁺ precursors in health and disease. *Nat Rev Drug Discov*. 2018;17(9):651–669. doi:10.1038/nrd.2018.98
6. Lautrup S, et al. NAD⁺ in brain aging and neurodegenerative disorders. *Cell Metab*. 2019;30(4):630–655. doi:10.1016/j.cmet.2019.09.001
7. Canto C, et al. NAD⁺ metabolism and the control of energy homeostasis. *Trends Mol Med*. 2015;21(6):429–441. doi:10.1016/j.molmed.2015.03.001
8. Yoshino J, et al. Nicotinamide mononucleotide, a key NAD⁺ intermediate, treats diet- and age-induced diabetes in mice. *Cell Metab*. 2011;14(4):528–536. doi:10.1016/j.cmet.2011.08.014
9. Trammell SAJ, et al. Nicotinamide riboside is a newly discovered NAD⁺ precursor vitamin in humans. *Nat Commun*. 2016;7:12948. doi:10.1038/ncomms12948
10. Fang EF, et al. NAD⁺ replenishment improves mitochondrial and stem cell function and enhances life span in mice. *Science*. 2016;352(6292):1436–1443. doi:10.1126/science.aaf2693